Skip to main content
Clinical Trials/NCT01192321
NCT01192321TerminatedPhase 4

Visual Outcomes After Bilateral Surgical Cataract Phacoemulsification: AcrySof Toric Intraocular Lens (IOL) Implantation Compared to Monofocal IOL Implantation

Alcon Research1 site in 1 country9 target enrollmentStarted: June 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Terminated
Enrollment
9
Locations
1
Primary Endpoint
Uncorrected Distance Visual Acuity

Study Overview

Brief Summary

The objectives of this study are to assess and compare bilateral uncorrected distance visual acuity and distance spectacle independence post bilateral implantation of AcrySof Toric Intraocular Lenses (IOLs) and monofocal IOLs. Secondary outcomes will include cost of eyeglass purchased and patient vision-related quality of life.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •are willing and able to understand and sign an informed consent;
  • •are willing and able to attend postoperative examinations per protocol schedule;
  • •are ≥ 21 years of age, of either gender and any race;
  • •have bilateral, age related, cataracts;
  • •have planned cataract removal via phacoemulsification with implantation of an intraocular lens (IOL);
  • •are available to undergo second eye surgery within 6 weeks of the first eye surgery;
  • •are in good ocular health, with the exception of cataracts;
  • •are free of disease(s)/condition(s) listed in the "Precautions" section of the AcrySof Toric and monofocal package inserts: choroidal hemorrhage, chronic severe uveitis, concomitant severe eye disease, extremely shallow anterior chamber, medically uncontrolled glaucoma, microphthalmos, non-age-related cataract, proliferative diabetic retinopathy (severe), severe corneal dystrophy, severe optic nerve atrophy, irregular corneal astigmatism and color vision deficiencies.
  • •have regular corneal astigmatism;
  • •qualify for bilateral AcrySof Toric IOLs on the AcrySof Toric Calculator (www.acrysoftoriccalculator.com)
  • •are able to obtain pupil dilation ≥ 5.0 mm
  • •are able to read and understand one of the following languages: Dutch, French, German

Exclusion Criteria

  • •previous corneal surgery and/or reshaping
  • •abnormality, disease and/or conditions of the cornea (i.e. keratoconus, corneal dystrophy, keratitis, corneal scar, etc.), which would clinically contra-indicate the implantation of a toric intraocular lens
  • •planned multiple procedures during cataract/IOL implantation surgery
  • •planned limbal relaxing incision (LRI), Excimer laser treatment or similar procedure prior to or during the course of the study
  • •an ocular disease and/or condition that may compromise visual acuity levels (i.e. glaucoma, diabetic retinopathy, amblyopia, etc.)
  • •pregnant, lactating or planning pregnancy during course of study. Subjects who become pregnant during the study will not be discontinued; however, data may be excluded from the effectiveness analyses because pregnancy can alter refraction and visual acuity results. Data will be collected on the CRF as observations.

Arms & Interventions

Toric T3 - T9

Experimental

Bilateral implantation of a Toric intraocular lens (IOL) models T3, T4, T5, T6, T7, T8 or T9

Intervention: Toric T3 - T9 (Device)

Monofocal

Active Comparator

Bilateral implantation of a monofocal intraocular lens (IOL) model with no toric component.

Intervention: Monofocal (Device)

Outcomes

Primary Outcomes

Uncorrected Distance Visual Acuity

Time Frame: 6 Months After Surgery

Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity.

Spectacle Independence

Time Frame: 6 Months After Surgery

Spectacle Independence (the ability of the patient to go without corrective lenses) measured by a subjective patient questionnaire.

Secondary Outcomes

  • Vision-related Quality of Life(6 Months After Surgery)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials